The Weinberg Group
The Weinberg Group is a global regulatory and compliance services firm serving pharmaceutical, biotechnology, and medical device organizations across the full product lifecycle, spanning regulatory consulting, CRO, quality compliance, pharmacovigilance, FSP, and digital transformation services with AI-augmented medical information and quality workflows.
- Company typePrivate
- Founded1999
- HeadquartersWashington, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What The Weinberg Group does
The Weinberg Group is a global regulatory and compliance services firm serving pharmaceutical, biotechnology, and medical device organizations across the full product lifecycle. The company operates an integrated portfolio spanning seven core service areas: Regulatory Sciences (covering FDA, EMA, and other national competent authorities for drugs, biologics, medical devices, and diagnostics across pre- and post-approval), CRO Services (multi-phase clinical development and decentralized trial support), Quality & Compliance (GxP auditing, computer system validation, inspection readiness), Pharmacovigilance (clinical and post-marketing safety, QPPV/LPPV, case and signal management), Medical Information (24/7/365 global contact centers, adverse event and complaint intake, patient support), FSP Solutions (embedded functional service provider teams across clinical operations, biostatistics, data sciences, and medical writing), and Digital Transformation (digital blueprint, data strategy, technology services, and validation). AI and ML are deployed within quality compliance and medical information workflows, including a generative AI capability for medical information delivery recognized by ECCCSA in 2025.
The business model is professional services, monetized through bespoke partnership engagements and FSP embedded-team contracts with enterprise life sciences clients. Pricing is not publicly disclosed and is structured around customized scopes rather than standardized SKUs. The go-to-market motion is direct enterprise field sales, executed through dedicated program managers and asset strategists who operate as extensions of client internal teams. Customer segmentation is horizontal across pharma, biotech, and medical device categories, with additional verticalization via therapeutic-area service lines (including cell and gene therapy) and a Digital Transformation practice that bridges life sciences and technology. The firm maintains SOC 1 and SOC 2 Type 2 compliance, has validated SBTi-approved net-zero targets, and operates a global footprint with offices referenced in the UK (HQ) and Sweden.
Data limitations are notable: there is no disclosed revenue, no customer logos or concentration data, and the firmographic record lists 101–250 employees against a 1983 founding date for The Weinberg Group (Washington, US), while related entity ProPharma Group MIS Limited is registered in England and Wales (company number 03671574) with a 1999 founding date and overlapping service descriptions. The firm's evolution into a global multi-service life sciences platform is supported by recent leadership additions (CCO in May 2026, VP HEOR and Market Access in June 2026) and recognition across regulatory, clinical trials, and AI excellence programs.
The Weinberg Group firmographics
Firmographics- Name
- The Weinberg Group
- Legal name
- ProPharma Group MIS Limited
- Website
- https://weinberggroup.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- The Weinberg Group is a global regulatory and compliance services firm serving pharmaceutical, biotechnology, and medical device organizations across the full product lifecycle, spanning regulatory consulting, CRO, quality compliance, pharmacovigilance, FSP, and digital transformation services with AI-augmented medical information and quality workflows.
- Ownership category
- akta.pro rank
The Weinberg Group industry classification
Industry- Product category
- Life Sciences Regulatory and Compliance Consulting
- NAICS
- Scientific Research and Development Services (5417), Management Consulting Services (54161)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)
- akta.pro secondary industries
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where The Weinberg Group is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
The Weinberg Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Regulatory Sciences Consulting: Comprehensive regulatory consulting services including FDA regulatory consulting, European regulatory development, marketing authorization holder partnerships, regulatory operations, and global medical writing. Supports pre- and post-approval regulatory submissions for drugs, biologics, medical devices, and diagnostics.
- CRO Services: Full-service contract research organization services including site and patient services, biostatistics and programming, and medical device clinical support for multi-phase clinical development.
- Quality & Compliance Services: GxP compliance and auditing, computer system validation, inspection readiness, clinical quality assurance, and commissioning qualification validation services.
- Pharmacovigilance Solutions: Clinical and post-marketing pharmacovigilance services including safety systems, QPPV/LPPV support, case management, signal management, and global ICSR submissions.
- Medical Information Services: Global contact center support, adverse event intake, product complaint handling, patient support services, and medical communications with 24/7/365 availability.
- FSP Solutions: Functional service provider solutions as an extension of client internal teams, including clinical operations, data sciences, biostatistics, medical writing, and decentralized clinical trials.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
The Weinberg Group product offering
Product offeringCore offering
The Weinberg Group delivers regulatory and compliance consulting services to pharmaceutical, biotechnology, and medical device companies across the entire product lifecycle. Through its affiliated ProPharma organization, it provides a full suite including Regulatory Sciences, CRO (Contract Research Organization) Services, Quality & Compliance, Pharmacovigilance, Medical Information, Functional Service Provider (FSP) Solutions, and Digital Transformation Services. These offerings support clients with submissions, clinical development, quality systems, safety surveillance, scientific communications, and technology-enabled transformation initiatives.
Product overview
ProPharma is a comprehensive life sciences consulting organization offering an end-to-end suite of bespoke services across the full product lifecycle. The core portfolio includes seven major service areas: Regulatory Sciences (FDA, EMA, and global regulatory support), CRO Services (clinical development and study execution), Quality & Compliance (GxP compliance and validation), Pharmacovigilance Solutions (safety monitoring from clinical through post-approval), Medical Information (24/7 contact centers and medical communications), FSP Solutions (functional service provider model for clinical operations), and Digital Transformation (technology enablement for life sciences). The company also operates across multiple therapeutic areas including Oncology, Cardiovascular, CNS, Infectious Disease/Vaccines, Cell and Gene Therapy, Ophthalmology, Pediatrics, Rare Disease, Respiratory, and Obesity & Diabetes. Services are designed to be customizable and partnership-driven, enabling clients to navigate regulatory, clinical, and compliance challenges throughout drug, biologic, medical device, and diagnostic development.
Differentiator
Problem solved
Functional benefit
Products and services
- Regulatory Sciences
Companies that use The Weinberg Group
Customer profileSegments3 records
Ideal customer profiles1 record
The Weinberg Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
The Weinberg Group partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights6 records
The Weinberg Group competitors and assessment
Company assessmentDirect peers
- Real Chemistry: Healthcare and life sciences consulting firm offering medical affairs, regulatory, and commercial services. Comparable in size and scope, particularly in medical communications and HEOR capabilities.
- Worldwide Clinical Trials: Mid-sized global CRO offering clinical trial, biostatistics, and regulatory services to pharma and biotech. Comparable in scale, service breadth, and customer mix to the company.
- Medpace: Mid-sized full-service CRO focused on small and mid-sized biopharma, with strong therapeutic expertise. Closely comparable business model and customer profile, though with a heavier clinical trial focus.
Broad incumbents
- Parexel International: Large global CRO with deep regulatory, clinical, and market access capabilities, particularly strong in regulatory consulting and biopharmaceutical services. Direct competitor in the same enterprise customer segment.
- Syneos Health: Large biopharmaceutical services organization combining CRO and contract commercial services. Competes across clinical, regulatory, and FSP engagements with global scale.
- ICON plc: Major global CRO providing clinical research, consulting, and FSP services to pharma and biotech. Directly comparable in CRO and FSP offerings, with broader scale and a more extensive therapeutic area footprint.
- IQVIA: The largest global CRO and life sciences services provider, offering clinical research, regulatory, and technology services. Competes with the company across CRO, regulatory consulting, and FSP engagements, but at significantly greater scale.
- Labcorp Drug Development (Fortrea): Spin-off of Labcorp's CRO business, offering full-service clinical development and central laboratory services. Competes across CRO and FSP engagements with global delivery capability.
- Charles River Laboratories: Major CRO with strengths in preclinical, discovery, and clinical development services. Adjacent competitor in early-phase and cell/gene therapy support.
Emerging players
- Veeva Systems: Life sciences cloud platform provider with strong regulatory and quality management software offerings. Adjacent competitor, particularly in the Digital Transformation and regulatory operations segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
The Weinberg Group social profiles
Digital presenceThe Weinberg Group compliance and trust
Trust signalCompliance2 records
The Weinberg Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Weinberg Group leadership team
Management profileNumber of profiles
Profiles2 records
The Weinberg Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Weinberg Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Weinberg Group
What does The Weinberg Group do?
The Weinberg Group delivers regulatory and compliance consulting services to pharmaceutical, biotechnology, and medical device companies across the entire product lifecycle. Through its affiliated ProPharma organization, it provides a full suite including Regulatory Sciences, CRO (Contract Research Organization) Services, Quality & Compliance, Pharmacovigilance, Medical Information, Functional Service Provider (FSP) Solutions, and Digital Transformation Services. These offerings support clients with submissions, clinical development, quality systems, safety surveillance, scientific communications, and technology-enabled transformation initiatives.
Is The Weinberg Group a public or private company?
The Weinberg Group is a private company. It is classified as unknown and is currently operating.
When was The Weinberg Group founded?
The Weinberg Group was founded in 1999. It employs 101 to 250 people.
Where is The Weinberg Group based?
The Weinberg Group is headquartered in Washington, United States, in the North America region.
How does The Weinberg Group make money?
Six revenue lines are on record. Regulatory Sciences Consulting is the primary driver. The others are CRO Services, quality & Compliance Services, pharmacovigilance Solutions, medical Information Services and FSP Solutions.
Who are The Weinberg Group's main competitors?
Direct peers on record are Real Chemistry, Worldwide Clinical Trials and Medpace. Broad incumbents are Parexel International, Syneos Health, ICON plc, IQVIA, Labcorp Drug Development (Fortrea) and Charles River Laboratories. Veeva Systems is listed as an emerging player.
Does The Weinberg Group have an API?
No public API is recorded for The Weinberg Group.
What industry is The Weinberg Group in?
The Weinberg Group's product category is Life Sciences Regulatory and Compliance Consulting. Its primary akta.pro industry code is HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs, with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 5417 and its SIC code is 8731.